Nicotinamide mononucleotide (NMN) is an organic compound that plays an important role in the energy generation of human cells and is involved in the synthesis of intracellular NAD. Previous experiments have confirmed that nicotinamide mononucleotide W+NMN can increase NAD in various organs in experimental mice, thus inhibiting nerve and blood vessel aging, and also improving diabetic symptoms.
Health-care product、Medicinal
Health products, food and medicine:
1. NMN can alleviate and improve ischemic heart and brain tissue damage;
2. NMN can improve oxidation-related degenerative diseases and physical dysfunction;
3. The therapeutic effect of NMN on metabolic diseases;
4.NMN can be used in anti-aging and anti-oxidation;
5.NMN can lower LDL and reduce uric acid and neutral fats in the blood.
Nicotinamide mononucleotide (NMN) is an organic compound that plays an important role in the energy generation of human cells and is involved in the synthesis of intracellular NAD. Previous experiments have confirmed that nicotinamide mononucleotide W+NMN can increase NAD in various organs in experimental mice, thus inhibiting nerve and blood vessel aging, and also improving diabetic symptoms.
Health-care product、Medicinal
Health products, food and medicine:
1. NMN can alleviate and improve ischemic heart and brain tissue damage;
2. NMN can improve oxidation-related degenerative diseases and physical dysfunction;
3. The therapeutic effect of NMN on metabolic diseases;
4.NMN can be used in anti-aging and anti-oxidation;
5.NMN can lower LDL and reduce uric acid and neutral fats in the blood.
Product : | β-nicotinamid mononucleotide | CAC NO : | 1094-61-7 | |
Molceular formular : | C11H15N2O8P | Quantity : | 200kgs | |
Analysis | Specification | Result | ||
Physical Description | ||||
Appearance | White to off-white fine powder | White powder | ||
Appearance of solution | Clear and colorless | Clear and colorless | ||
PH | 3.0-4.0 | 3.2 | ||
Mesh size | 100% through 40 mesh | 40 mesh | ||
Bulk density | 0.15g/ml Min | 99.5% | ||
Tapped density | 0.3g/ml Min | 0.339% | ||
Chemical Tests | ||||
Assay | 98%~102% | 99.5% | ||
Purity (HPLC) | 98.0%Min | 99.5% | ||
Loss in drying | 1.0% Max | 0.339% | ||
Residual solvents(Ethanol) | 200ppm Max | <200ppm | ||
Chlorides | 200ppm Max | <200ppm | ||
Sulfates | 300ppm Max | <300ppm | ||
Heavy Metals | 10ppm Max | <10ppm | ||
As | 1ppm Max | <1ppm | ||
Microbiology Control | ||||
Tobal Plate Count | 30000cfu/g Max | 1000cfu/g | ||
Yeast &Mold | 50cfu/g Max | 25cfu/g | ||
Coliforms | 0.92MPN/g Max | 0.45MPN/g | ||
Staph Aureus | Negative /25g | Not detected | ||
Conclusion | Complies with the standads. |
Product : | β-nicotinamid mononucleotide | CAC NO : | 1094-61-7 | |
Molceular formular : | C11H15N2O8P | Quantity : | 200kgs | |
Analysis | Specification | Result | ||
Physical Description | ||||
Appearance | White to off-white fine powder | White powder | ||
Appearance of solution | Clear and colorless | Clear and colorless | ||
PH | 3.0-4.0 | 3.2 | ||
Mesh size | 100% through 40 mesh | 40 mesh | ||
Bulk density | 0.15g/ml Min | 99.5% | ||
Tapped density | 0.3g/ml Min | 0.339% | ||
Chemical Tests | ||||
Assay | 98%~102% | 99.5% | ||
Purity (HPLC) | 98.0%Min | 99.5% | ||
Loss in drying | 1.0% Max | 0.339% | ||
Residual solvents(Ethanol) | 200ppm Max | <200ppm | ||
Chlorides | 200ppm Max | <200ppm | ||
Sulfates | 300ppm Max | <300ppm | ||
Heavy Metals | 10ppm Max | <10ppm | ||
As | 1ppm Max | <1ppm | ||
Microbiology Control | ||||
Tobal Plate Count | 30000cfu/g Max | 1000cfu/g | ||
Yeast &Mold | 50cfu/g Max | 25cfu/g | ||
Coliforms | 0.92MPN/g Max | 0.45MPN/g | ||
Staph Aureus | Negative /25g | Not detected | ||
Conclusion | Complies with the standads. |